Literature DB >> 810484

Genetic analysis of drug resistance in Neisseria gonorrhoeae: production of increased resistance by the combination of two antibiotic resistance loci.

T W Maier, L Zubrzycki, M B Coyle, M Chila, P Warner.   

Abstract

The studies reported here demonstrate that increased resistance of Neisseria gonorrhoeae to penicillin, tetracycline, and chloramphenicol results from the combined effect of two resistance loci. As shown by experiments with deoxyribonucleic acid from transformants carrying only a single resistance locus, transformants with an incresed level of resistance to penicillin result from the combination of a penicillin-specific locus, pen, and a multiple resistance locus, mtr. Similarly, transformants with an increased level of resistance to tetracycline result from the combination of mtr and a tetracycline-specific locus, tet. Transformants with an increased level of resistance to chloramphenicol result from the combination of mtr and a chloramphenicol-specific locus, cml. Deoxyribonucleic acid dilution experiments established that only a single dose of each of the two required resistance loci is necessary to give higher-level resistance. Higher-level-resistant transformants were not obtained when a double dose of one resistance locus or a combination of loci pairs other than mtr and pen, mtr and tet, or mtr and cml was introduced into a recipient. Combinations of the mtr and tet genes resulted in increased resistance to semisynthetic tetracyclines. The presence of the mtr and pen genes resulted in increased resistance to penicillinase-stable penicillins.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810484      PMCID: PMC235974          DOI: 10.1128/jb.124.2.834-842.1975

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  26 in total

1.  Analysis of the complex sulfonamide resistance locus of pneumococcus.

Authors:  R D HOTCHKISS; A H EVANS
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1958

2.  Genetic studies on microbial cross resistance to toxic agents. IV. Cross resistance of Bacillus megaterium to forty-four antimicrobial drugs.

Authors:  W SZYBALSKI
Journal:  Appl Microbiol       Date:  1954-03

3.  Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics.

Authors:  W SZYBALSKI; V BRYSON
Journal:  J Bacteriol       Date:  1952-10       Impact factor: 3.490

4.  Production of Staphylococcus Strains Resistant to Various Concentrations of Penicillin.

Authors:  M Demerec
Journal:  Proc Natl Acad Sci U S A       Date:  1945-01       Impact factor: 11.205

5.  The genetic relationship and phenotypic expression of mutations endowing Pneumococcus with resistance to erythromycin.

Authors:  A W RAVIN; V N IYER
Journal:  J Gen Microbiol       Date:  1961-10

6.  Patterns of resistance to antimicrobial agents.

Authors:  V BRYSON; M DEMEREC
Journal:  Ann N Y Acad Sci       Date:  1950-09       Impact factor: 5.691

7.  Cell-surface alterations in Escherichia coli K-12 with chromosmal mutations changing ampicillin resistance.

Authors:  H G Boman; S Jonsson; D Monner; S Normark; G D Bloom
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

8.  Genetic analysis of drug resistance in Neisseria gonorrhoeae: identification and linkage relationships of loci controlling drug resistance.

Authors:  T W Maier; L Zubrzycki; M B Coyle
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

9.  Present pattern of antibiotic sensitivity of gonococcal strains isolated in Bombay.

Authors:  J M Moses; M S Desai; C B Bhosle; M S Trasi
Journal:  Br J Vener Dis       Date:  1971-08

10.  Studies on transformations of Hemophilus influenzae. I. Competence.

Authors:  S H GOODGAL; R M HERRIOTT
Journal:  J Gen Physiol       Date:  1961-07       Impact factor: 4.086

View more
  19 in total

1.  Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae.

Authors:  L F Guymon; D L Walstad; P F Sparling
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

Review 2.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

3.  Genetic analysis and penicillin-binding protein alterations in Neisseria gonorrhoeae with chromosomally mediated resistance.

Authors:  T J Dougherty
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 4.  Genetic loci and linkage associations in Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  S E West; V L Clark
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Vancomycin hypersusceptibility in Neisseria gonorrhoeae isolated from patients involves diverse mutations.

Authors:  J A Koelbl; B W Catlin
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

6.  Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.

Authors:  J C Pechère
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Genetic analysis of spontaneous resistance to ampicillin in Neisseria gonorrhoeae.

Authors:  F Jones; E J Cunningham; T E Shockley; J H Jackson
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

8.  Multiple low-level antibiotic resistance in Aeromonas salmonicida.

Authors:  S C Wood; R N McCashion; W H Lynch
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

Review 9.  Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.

Authors:  F Malouin; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

10.  Absence of penicillin-degrading enzymes in penicillin-resistant strains of Neisseria gonorrhoeae.

Authors:  J L Beebe; P Ligeti; T J Wlodkowski
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.